Epidemiology and Management of Cutaneous T-Cell Lymphoma at Hospital México, Costa Rica.
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCaja Costarricense de Seguro Social
About this trial
Adult patients (≥18 years) with confirmed cutaneous T-cell lymphoma evaluated at Hospital México between 2019 and 2025 will be retrospectively analyzed using EDUS records to describe their epidemiological profile, clinical characteristics, treatments, and outcomes.
Eligibility criteria
Qualifiers
Patients with a confirmed diagnosis of cutaneous T-cell lymphoma, established through clinical, histopathological, and immunohistochemical criteria, documented in EDUS of Hospital México in the Dermatology Service of Hospital México during the period between January 2019 and December 2025.
Patients aged 18 years or older, of both sexes.
Patients with at least one dermatological evaluation recorded during the study period.
Patients who, having a confirmed diagnosis, have received some modality of treatment, including skin-directed therapies (phototherapy, topical treatments, localized radiotherapy) and/or systemic treatments.
Disqualifiers
Clinical records that are insufficient or incomplete, preventing adequate diagnostic classification, staging, therapeutic characterization, or evaluation of clinical evolution.
Patients with a presumptive diagnosis of cutaneous T-cell lymphoma without histopathological confirmation.
Duplicate or inconsistent records that hinder the correct identification and classification of the patient.
Patients attended outside the established study period.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov